Selective Ultrasound Screening for DDH 1991-2006
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01866527|
Recruitment Status : Completed
First Posted : May 31, 2013
Last Update Posted : May 31, 2013
Early treatment is considered essential for developmental dysplasia of the hip (DDH), but the choice of screening strategy is debated. The investigators evaluated the effect of a selective ultrasound (US) screening programme.
All infants born in a defined region during 1991-2006 with increased risk of DDH, i.e. clinical hip instability, breech presentation, congenital foot deformities or a family history of DDH, were subjected to US screening at age one to three days. Severe sonographic dysplasia and/or dislocatable/dislocated hips were treated with abduction splints. Mild dysplasia and/or pathological instability, i.e. not dislocatable/dislocated hips were followed clinically and sonographically until spontaneous resolution, or until treatment became necessary. The minimum observation period was 5,5 years.
|Condition or disease|
|Developmental Dysplasia of the Hip|
Of 81564 newborns, 11539 (14,1%) were identified as at risk, of which 11190 (58% girls) were included for further analyses. Of the 81564 infants, 2433 (3•0%) received early treatment; 1882 (2,3%) from birth and 551 (0,7%) after six weeks or more of clinical and sonographic surveillance. Another 2700 (3,3%) normalised spontaneously after watchful waiting from birth. Twenty-six infants (0,32 per 1000, 92% girls, two from the risk group) presented with late subluxated/dislocated hips (after one month of age). Another 126 (1,5 per 1000, 83% girls, one from the risk group) were treated after isolated late residual dysplasia. Thirty-one children (0,38 per 1000) had surgical treatment before age five years. Avascular necrosis was diagnosed in seven of all children treated (0.27%), four after early and three after late treatment.
Interpretation The first 16 years of a standardised selective US screening programme for DDH resulted in acceptable rates of early treatment and US follow-ups, and low rates of late subluxated/dislocated hips compared to similar studies.
|Study Type :||Observational|
|Actual Enrollment :||81564 participants|
|Official Title:||Selective Ultrasound Screening for Developmental Hip Dysplasia: Effect on Management and Late Detected Cases. A Prospective Survey During 1991-2006.|
|Study Start Date :||January 1991|
|Primary Completion Date :||August 2012|
|Study Completion Date :||August 2012|
all newborns born 1991-2006
all newborns born 1991-2006
- late dislocated or subluxated hips [ Time Frame: first 5 years of life ]late detected after 1 month of life, requiring treatment
- Number of participants who receive ultrasound follow-up for 6 weeks or more [ Time Frame: first months of life ]Number of participants who receive ultrasound follow-up (i.e sonographic surveillance) for 6 weeks or more
- early treatment [ Time Frame: first months of life ]abduction treatment for DDH
- first surgical treatment [ Time Frame: first five years of life ]the need for a first surgical treatment the first 5 years of life (closed and open reductions, osteotomies)
- avascular necrosis of femoral head [ Time Frame: first five years of life ]avascular necrosis of femoral head as complication to treatment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01866527
|Paediatric section, Radiology department, Haukeland University hospital, Bergen, Norway|
|Bergen, Norway, 5021|
|Study Director:||Karen Rosendahl, PhD||Paediatric Section, Department of Radiology, Haukeland University hospital, Bergen|